| PRODUKT |
CATALOG # |
DESCRIPTION |
AMOUNT |
|
sc-202421 |
A nonselective K+ channel blocker that has been used to characterize and study the blockage of K+ channels. Has been shown to bind from the cytoplasmic side of the cell membrane. |
5 g |
|
sc-204768 |
Oral hypoglycemic agent that enhances insulin secretion by inhibiting metabolic clearance. ATP-dependent K+ channels blocker in pancreatic b cells and brain GABA containing neurons resulting in insulin release. |
100 mg/1 g |
|
sc-3587 |
Noxiustoxin is a 39 amino acid peptide that has shown to induce neurotransmitter release from the blockage of K+ channels. |
5 µg |
|
sc-215772 |
An antiarrhythmic potassium channel blocker. (Class IA ) |
5 g/10 g |
|
sc-202834 |
K+ channel blocker and antagonist of nicotinic cholinergic receptor. Ganglionic blocking agent. |
5 g |
|
sc-202841 |
Stimulates pancreatic islet cells to secrete insulin; blocks ATP-sensitive K+ channels. |
1 g |
|
sc-358792 |
Inhibits the renal, outer medullary potassium channel (ROMK, Kir1.1), Kir7.1 while not affecting Kir2.1 or Kir4.1. Acts as an intracellular ROMK channel pore blocker. |
10 mg/50 mg |
